Physique Pharma ARA-290 is a research-grade peptide supplied in sterile 3mL vials, containing 10 mg of ARA-290 per vial. This formulation is designed for controlled laboratory research exploring tissue-protective signaling, inflammatory modulation, and cellular repair pathways associated with erythropoietin-derived peptide activity.

ARA-290:

ARA-290 is a synthetic peptide derived from erythropoietin (EPO) research, commonly studied in laboratory settings for its potential involvement in cellular repair signaling, anti-inflammatory mechanisms, and protective responses in nerve and tissue models. It is frequently examined in peptide research to better understand regenerative pathways, immune response regulation, and cellular resilience in experimental environments.

Each vial is securely sealed to maintain sterility and ensure stability and consistency across experimental applications.

Key Features:

⚗️ 10 mg ARA-290 in a sterile 3 mL vial, supplied as a lyophilised (freeze-dried) powder form

💧 Research-grade formulation for laboratory use

🔬 Supports tissue-protective and inflammation-related research

🧴 Sealed vial for stability and peptide integrity🇦🇺 Australian supplied Physique Pharma quality

Intended Use:

Physique Pharma ARA-290 is intended for laboratory research purposes only, including:

• Studying cellular repair and protective peptide pathways

• Investigating inflammation-regulating mechanisms in experimental models

• Supporting advanced peptide, nerve, and tissue-based research

• Exploring erythropoietin-derived signaling activity

Not for human or animal use.

Physique Pharma – Precision, purity, and dependable peptide research performance.